Metabolic syndrome: frequency of its components and global risk for coronary heart disease

被引:0
作者
Ignacio Coniglio, Raul
Nellem, Jorge
Sibechi, Norberto
Colombo, Osvaldo
机构
来源
ACTA BIOQUIMICA CLINICA LATINOAMERICANA | 2011年 / 45卷 / 03期
关键词
metabolic syndrome; frequency of components; global risk for coronary heart disease (Framingham Study); CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; OBESITY; ASSOCIATION; PATHOPHYSIOLOGY; ATHEROSCLEROSIS; HYPERTENSION; DYSFUNCTION; MECHANISMS; MANAGEMENT;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The metabolic syndrome (MS) includes an aggregate of components that is associated with the risk of diabetes mellitus and atherosclerosis. The calculation of the global risk score (GR) for coronary disease (Framingham Study) allows their categorization. The objectives of this work were to describe: a) the frequency of the associations of the MS components; b) the distribution of the frequency of low, moderate and high GR values in employees with MS defined by the National Cholesterol Education Program (ATP III). From an observational and multicentric study of 2,806 employees of both sexes between 40-65 years old from Argentina 625 subjects with MS were selected. The frequency of subjects with three components was 67.4%, 28.6% with four, and 4% with five. The most frequent combination in men was central obesity with arterial pressure >= 130/85 mmHg or treated and triglycerides >= 150 mg/dL 26.5%. In women, it was similar but, 20.5% were with low HDL cholesterol. In men, 26.5% had MS without central obesity and 27.8% had MS with glucose >= 110 mg/dL. Moderate or high GR was found in 62.2% of men and 13.9% of women, but 37.8% of men and 86.1% of women had low GR. The results showed the heterogeneity of MS presentation according to the frequency of its components, and they indicate the need to include GR in the clinical evaluation.
引用
收藏
页码:413 / 421
页数:9
相关论文
共 39 条
  • [1] Akosah Kwame O, 2006, J Cardiometab Syndr, V1, P173, DOI 10.1111/j.1559-4564.2006.05780.x
  • [2] Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
    Alberti, K. G. M. M.
    Eckel, Robert H.
    Grundy, Scott M.
    Zimmet, Paul Z.
    Cleeman, James I.
    Donato, Karen A.
    Fruchart, Jean-Charles
    James, W. Philip T.
    Loria, Catherine M.
    Smith, Sidney C., Jr.
    [J]. CIRCULATION, 2009, 120 (16) : 1640 - 1645
  • [3] The metabolic syndrome - a new worldwide definition
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. LANCET, 2005, 366 (9491) : 1059 - 1062
  • [4] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [5] 2-S
  • [6] Balkau B, 1999, DIABETIC MED, V16, P442
  • [7] The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
    Bonora, E
    Targher, G
    Formentini, G
    Calcaterra, F
    Lombardi, S
    Marini, F
    Zenari, L
    Saggiani, F
    Poli, M
    Perbellini, S
    Raffaelli, A
    Gemma, L
    Santi, L
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETIC MEDICINE, 2004, 21 (01) : 52 - 58
  • [8] Coniglio Raúl I, 2009, Medicina (B. Aires), V69, P246
  • [9] Davidson Jaime A, 2007, Endocr Pract, V13, P77
  • [10] Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD
    Eckel, Robert H.
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2007, 66 (01) : 82 - 95